Skip to main content
. 2021 Mar 31;11(12):5778–5793. doi: 10.7150/thno.55946

Table 1.

Characteristics of the study cohort

Control (N=30) ACS (N=67) ACS-statins (N=36) P value
Age* 54.87±7.65 62.03±10.95 62.33±9.52 0.003bc
Male* 12 (40.0) 48 (71.6) 29 (80.6) <0.001bc
SBP* 117.80±9.56 131.64±18.94 125.75±14.94 0.001bc
BMI* 24.35±2.82 26.47±3.23 26.52±3.09 0.005bc
No. sv§
NA NA 2 (3.0) 3 (8.3) NA
1 NA 22 (32.8) 7 (19.4) NA
2 NA 17 (25.4) 6 (16.7) NA
3 NA 26 (38.8) 20 (55.6) NA
Type of ACS§
UA NA 48 (71.6) 27 (75.0) NA
NSTEMI NA 12 (17.9) 3 (8.3) NA
STEMI NA 7 (10.5) 6 (16.7) NA
Gensini# NA 32.5 (18,55) 33 (22,50) ns
Medications
HTN drug§ 4 (13.3) 39 (58.2) 24 (66.7) <0.001bc
OAD§ 1 (3.3) 17 (25.4) 16 (44.4) 0.001abc
Smoke history§ 4 (13.3) 39 (58.2) 20 (55.6) <0.001bc
Drink history§ 3 (10.0) 35 (52.2) 19 (52.8) <0.001bc
HTN§ 6 (20.0) 44 (65.7) 23 (63.9) <0.001bc
T2DM§ 1 (3.3) 17 (25.4) 16 (44.4) 0.001abc
HLP§ 8 (26.7) 31 (46.3) 30 (83.3) <0.001ac
OMI§ 0 (0.0) 13 (19.4) 2 (5.6) 0.009b
Laboratory data
TC* 4.81±0.87 4.02±0.88 3.81±1.30 <0.001bc
TG* 1.54±0.95 1.64±0.70 1.65±1.01 ns
HDL-C* 1.22±0.35 0.97±0.23 0.92±0.15 <0.001bc
LDL-C* 2.82±0.75 2.35±0.76 2.14±1.04 0.005bc
hsCRP 0.66 (0.37,1.21) 2.13 (0.87,4.11) 2.03 (0.64,3.43) 0.001bc
cTnI 0.00 (0.00,0.00) 0.01 (0.00,0.05) 0.01 (0.00,0.04) <0.001bc

*mean ± SD, §n (%), #median (IQR).

For the difference comparison of clinical characteristics among the three groups, one-way analysis of variance (ANOVA) was employed in cases of continuous normally distributed data. The Bonferroni test was applied for post hoc comparisons in cases of equal variance, and the Tamhane test was applied in cases of unequal variance. The Kruskal-Wallis H-test was applied for continuous data that were not normally distributed among the three groups, and the Mann-Whitney U test was applied for this kind of data between two groups. Categorical variables were compared by the χ2 test or Fisher's exact test. NA: not available. SBP: systolic blood pressure. BMI: body mass index. No.sv: number of stenosed vessels. HTN: hypertension. OAD: oral anti-diabetic drugs. T2DM: type 2 diabetes mellitus. HLP: hyperlipidemia. OMI: old myocardial infarction. TC: total cholesterol. TG: triacylglycerol. HDL-C: high-density lipoprotein cholesterol. LDL-C: low-density lipoprotein cholesterol. hsCRP: high sensitivity C-reactive protein. cTnI: cardiac troponin I. a: ACS-statins vs ACS. b: ACS versus Control. c: ACS-statins vs Control.